Ashley Cordova has served as Novocure’s Chief Executive Officer (CEO) since January 2025.

Prior to becoming CEO, she was the company’s Chief Financial Officer (CFO), from 2020 through 2024. As CFO Ms. Cordova was responsible for the global oversight of Novocure’s revenue and financial operations, including product reimbursement, financial reporting, financial planning and analysis, treasury, tax, and investor relations.

Throughout her tenure, Ms. Cordova has been integral to building Novocure’s global organization and positioning the company for each stage of its growth.

Ms. Cordova joined Novocure in June 2014 as Director of Global Treasury and was promoted to roles of increasing seniority before becoming the Senior Vice President, Finance and Investor Relations from 2018 to 2020.

Before joining Novocure, Ms. Cordova served in various financial roles at Zoetis Inc. from 2012 to 2014 and Pfizer Inc. from 2005 to 2012.

Ms. Cordova graduated with a bachelor’s degree in Music and Business from Furman University and earned her International Master of Business Administration from the University of South Carolina.